Feng S, Lin W, Lee I, Luo S, Wang C
Biomedicines. 2024; 12(3).
PMID: 38540122
PMC: 10967704.
DOI: 10.3390/biomedicines12030509.
Li F, Patterson A, Krausz K, Dick B, Frey F, Gonzalez F
Biochem Pharmacol. 2012; 83(10):1435-44.
PMID: 22387617
PMC: 3665348.
DOI: 10.1016/j.bcp.2012.02.013.
Caron J, Libersa C
Drug Saf. 1997; 17(1):8-36.
PMID: 9258628
DOI: 10.2165/00002018-199717010-00002.
Bitton Y, Karin J, David D, Akselrod S
Clin Auton Res. 1996; 6(6):313-9.
PMID: 8985619
DOI: 10.1007/BF02556301.
Geleris P, Boudoulas H, Schaal S, Lewis R, Lima J
Eur J Clin Pharmacol. 1980; 18(4):311-4.
PMID: 7439250
DOI: 10.1007/BF00561387.
Efficacy of intravenous procainamide infusion in converting atrial fibrillation to sinus rhythm. Relation to left atrial size.
Halpern S, Ellrodt G, Singh B, Mandel W
Br Heart J. 1980; 44(5):589-95.
PMID: 7437202
PMC: 482449.
DOI: 10.1136/hrt.44.5.589.
Anaesthetic problems associated with the treatment of cardiovascular disease: I. Digitalis toxicity.
Chung D
Can Anaesth Soc J. 1981; 28(1):6-16.
PMID: 7237204
DOI: 10.1007/BF03007283.
Effect of lidocaine on the electrophysiological properties of ventricular muscle and purkinje fibers.
BIGGER Jr J, Mandel W
J Clin Invest. 1970; 49(1):63-77.
PMID: 5409809
PMC: 322445.
DOI: 10.1172/JCI106224.
Blood levels of lignocaine after intramuscular administration to patients with proven or suspected acute myocardial infarction.
Ryden L, Wasir H, Conradsson T, Olsson B
Br Heart J. 1972; 34(10):1012-7.
PMID: 5086967
PMC: 458539.
DOI: 10.1136/hrt.34.10.1012.
Antiarrhythmic agents. II. Therapeutic considerations.
Mason D, DeMaria A, Amsterdam E, Zelis R, MASSUMI R
Drugs. 1973; 5(4):292-317.
PMID: 4724237
DOI: 10.2165/00003495-197305040-00003.
Effect of lidocaine hydrochloride on membrane conductance in mammalian cardiac Purkinje fibers.
Arnsdorf M, BIGGER Jr J
J Clin Invest. 1972; 51(9):2252-63.
PMID: 4639011
PMC: 292389.
DOI: 10.1172/JCI107034.
Controlled trial of prophylatic treatment with lidocaine in acute myocardial infarction.
BLEIFELD W, Merx K, Heinrich K, Effert S
Eur J Clin Pharmacol. 1973; 6(2):119-26.
PMID: 4588851
DOI: 10.1007/BF00562438.
Effects of a long-acting antiarrhythmic agent--QX-572--on therapy resistant ventricular tachyarrhythmias.
Ryden L, Hjalmarson A, Wasir H, WERKO L
Br Heart J. 1974; 36(8):811-21.
PMID: 4413111
PMC: 458899.
DOI: 10.1136/hrt.36.8.811.
Antiarrhythmic agents. I. Mechanisms of action and clinical pharmacology.
Mason D, DeMaria A, Amsterdam E, Zelis R, MASSUMI R
Drugs. 1973; 5(4):261-91.
PMID: 4146767
DOI: 10.2165/00003495-197305040-00002.
Poisoning due to class IA antiarrhythmic drugs. Quinidine, procainamide and disopyramide.
Kim S, Benowitz N
Drug Saf. 1990; 5(6):393-420.
PMID: 2285495
DOI: 10.2165/00002018-199005060-00002.
Procainamide absorption studies to test the feasibility of using a sustained-release preparation.
Shaw T, Kumana C, Kaye C, Padgham C, Kaspi T, Hamer J
Br J Clin Pharmacol. 1975; 2(6):515-9.
PMID: 1234015
PMC: 1402637.
DOI: 10.1111/j.1365-2125.1975.tb00569.x.
Antazoline therapy of recurrent refractory supraventricular arrhythmias--a preliminary report.
Downar E, Waxman M
Can Med Assoc J. 1975; 113(5):391-3.
PMID: 1098755
PMC: 1956655.
Adverse reactions to procainamide.
Lawson D, Jick H
Br J Clin Pharmacol. 1977; 4(5):507-11.
PMID: 911600
PMC: 1429167.
DOI: 10.1111/j.1365-2125.1977.tb00777.x.
Effects of halothane on the pharmacokinetics of lidocaine in digitalis-toxic dogs.
Boyce J, Cervenko F, WRIGHT F
Can Anaesth Soc J. 1978; 25(4):323-8.
PMID: 667674
DOI: 10.1007/BF03005657.
Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.
Anderson J, Harrison D, Meffin P, Winkle R
Drugs. 1978; 15(4):271-309.
PMID: 648399
DOI: 10.2165/00003495-197815040-00003.
